ClinConnect ClinConnect Logo
Search / Trial NCT06083298

Multifidus Cervicis and Inter-Semispinal Plane Blocks in Analgesia After Cervical Spine Surgery

Launched by ZAGAZIG UNIVERSITY · Oct 8, 2023

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Multifidus Cervicis Plane Block Inter Semispinal Plane Block Analgesia

ClinConnect Summary

This clinical trial is exploring two different methods of pain relief for patients undergoing cervical spine surgery. The goal is to determine which method provides better pain control after surgery, helping patients recover more effectively and return to their daily activities sooner. The techniques being compared are called multifidus cervicis plane block and inter-semispinal plane block. Both methods aim to reduce the need for strong pain medications, which can have side effects and complicate recovery.

To participate in this study, patients should be between 21 and 60 years old, have a body mass index (BMI) of 30 or less, and be scheduled for elective cervical spine surgery. However, those with certain health issues, allergies to the medications used, or a history of chronic pain may not be eligible. Participants can expect to receive one of the pain control techniques before their surgery and will be monitored for pain levels and recovery progress. This research is important because effective pain management can greatly improve the surgery experience and overall outcomes for patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient acceptance.
  • Age 21-60 years old.
  • BMI ≤ 30 kg/m2
  • ASA I - II.
  • Elective posterior cervical spine surgery under general anesthesia.
  • Exclusion Criteria:
  • History of allergy to the LA agents used in this study
  • Skin lesion at the needle insertion site,
  • Those with bleeding disorders, sepsis, liver disease, and psychiatric disorders
  • History of chronic pain and taking analgesics
  • History of cognitive dysfunction or mental illness

About Zagazig University

Zagazig University, a prominent educational and research institution located in Egypt, plays a pivotal role in advancing medical knowledge and promoting health innovations through its clinical trials. With a commitment to excellence in research, the university leverages its diverse expertise and state-of-the-art facilities to conduct rigorous clinical studies that aim to improve patient care and outcomes. By fostering collaboration among multidisciplinary teams, Zagazig University contributes significantly to the global medical community, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements.

Locations

Zagazig, Alsharqia, Egypt

Patients applied

0 patients applied

Trial Officials

Shereen E Abd Ellatif, MD

Principal Investigator

Faculty of medicine, zagazig university

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported